Heterologous prime-boost vaccination with H3N2 influenza viruses of swine favors cross-clade antibody responses and protection
Influenza: More efficient, more protective vaccinations Boosting an influenza vaccine with a different strain offers twice the protection for half the volume of vaccine. Pigs and humans need two doses of killed influenza vaccine—a “priming” dose, with a “booster” given approximately 4 weeks after—in...
Guardado en:
Autores principales: | Kristien Van Reeth, José Carlos Mancera Gracia, Ivan Trus, Lieve Sys, Gerwin Claes, Han Versnaeyen, Eric Cox, Florian Krammer, Yu Qiu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d047b67c05bd434cbd6e74179417e3fd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Assessment of an LSDV-Vectored Vaccine for Heterologous Prime-Boost Immunizations against HIV
por: Ros Chapman, et al.
Publicado: (2021) -
Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy
por: Federica Cappuccini, et al.
Publicado: (2021) -
Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimens.
por: Emma T Crooks, et al.
Publicado: (2021) -
Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimens
por: Emma T. Crooks, et al.
Publicado: (2021) -
Broadly Reactive IgG Responses to Heterologous H5 Prime-Boost Influenza Vaccination Are Shaped by Antigenic Relatedness to Priming Strains
por: Jiong Wang, et al.
Publicado: (2021)